Charles River Laboratories International (CRL) Non-Current Debt (2016 - 2025)
Historic Non-Current Debt for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.
- Charles River Laboratories International's Non-Current Debt fell 606.88% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year decrease of 606.88%. This contributed to the annual value of $2.2 billion for FY2024, which is 1537.29% down from last year.
- As of Q3 2025, Charles River Laboratories International's Non-Current Debt stood at $2.2 billion, which was down 606.88% from $2.3 billion recorded in Q2 2025.
- Charles River Laboratories International's Non-Current Debt's 5-year high stood at $3.0 billion during Q2 2022, with a 5-year trough of $2.2 billion in Q3 2025.
- Its 5-year average for Non-Current Debt is $2.6 billion, with a median of $2.7 billion in 2024.
- As far as peak fluctuations go, Charles River Laboratories International's Non-Current Debt surged by 4697.35% in 2021, and later plummeted by 1537.29% in 2024.
- Over the past 5 years, Charles River Laboratories International's Non-Current Debt (Quarter) stood at $2.7 billion in 2021, then increased by 1.65% to $2.7 billion in 2022, then dropped by 2.23% to $2.6 billion in 2023, then dropped by 15.37% to $2.2 billion in 2024, then decreased by 2.44% to $2.2 billion in 2025.
- Its Non-Current Debt stands at $2.2 billion for Q3 2025, versus $2.3 billion for Q2 2025 and $2.5 billion for Q1 2025.